Endpoints News 生物医药· John Carroll·· 28 天前AI 评分26
第三季度生物医药行业受并购放缓影响承压
Biotech takes a hit as dealmakers take a knee in Q3
AI 导读
第三季度生物医药行业因并购活动放缓而面临冲击,此前上半年行业M&A交易热潮的势头明显降温。
正文
A chill wind blew through the biopharma industry in the third quarter as the pace of M&A from the first half of the year cooled …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.
来源:Endpoints News 生物医药 · endpoints.news